Nanotechnology could help fight diabetes
Injectable nanoparticles developed at Massachusetts Institute of Technology (MIT) may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin. The nanoparticles weAstraZeneca issues update on accelerated oncology
AstraZeneca today announced that it will be moving three of its cancer compounds forward to Phase III




